Welcome, Guest. Please login or register.
November 18, 2017, 01:09:16 PM

Login with username, password and session length

  • Total Posts: 722408
  • Total Topics: 58700
  • Online Today: 326
  • Online Ever: 1421
  • (August 13, 2016, 05:18:44 AM)
Users Online
Users: 5
Guests: 259
Total: 264


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Ohio: Case Western Reserve University Researcher Seeks Trigger for HIV Latency  (Read 1725 times)

0 Members and 1 Guest are viewing this topic.

Offline younghopefulpoz

  • Member
  • Posts: 55
Ohio: Case Western Reserve University Researcher Seeks Trigger for HIV Latency
From U.S. Centers for Disease Control and Prevention
April 25, 2012
The American Foundation for AIDS Research (amfAR) has announced its first research grants for 2012. The four $250,000 two-year awards are the latest grants among the more than $340 million the group has given since 1985 for HIV/AIDS education, prevention and treatment programs.
The recipient researchers are:
A California Institute of Technology team that is studying whether HIV continues to replicate when a patient has an undetectable viral load and, if so, how.
A Massachusetts General Hospital team that is focused on a newly discovered cell type that is resistant to antiretroviral therapy.
A team at Ghent University Hospital in Belgium that is developing a new test that can show a patient's viral load beyond levels currently deemed undetectable.
A Case Western Reserve University (CWRU) team that will seek to identify features of cells that are necessary to maintain HIV latency.
Leading the CWRU work is Jonathan Karn, a professor and chair of molecular biology and microbiology in the School of Medicine. Karn and his 10-person team are using specialized viruses to inactivate genes in these cells to identify targets for drugs that can treat and eradicate HIV, while not affecting anything else.
"The challenge in developing strategies for HIV is that the virus becomes silent. You have no way of touching it," Karn said. "The immune system can't see it. Drugs can't reach it. You have a reservoir sitting around in patients, even if they've been on intensive therapy for decades." During the next five years, Karn's team hopes to figure out how to reverse latency or prevent it from happening.




Terms of Membership for these forums

© 2017 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.